Documents
Application Sponsors
Marketing Status
Application Products
| 001 | INJECTABLE;INJECTION | 1000MG/40ML | 0 | GAZYVA | OBINUTUZUMAB | 
FDA Submissions
| TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2013-11-01 | PRIORITY | 
| LABELING; Labeling | SUPPL | 8 | AP | 2014-06-27 | STANDARD | 
| EFFICACY; Efficacy | SUPPL | 9 | AP | 2014-12-24 | STANDARD | 
| LABELING; Labeling | SUPPL | 10 | AP | 2015-09-23 | STANDARD | 
| EFFICACY; Efficacy | SUPPL | 13 | AP | 2016-02-26 | PRIORITY | 
| EFFICACY; Efficacy | SUPPL | 17 | AP | 2017-11-16 | PRIORITY | 
| LABELING; Labeling | SUPPL | 18 | AP | 2017-11-16 | STANDARD | 
| EFFICACY; Efficacy | SUPPL | 25 | AP | 2020-03-27 | PRIORITY | 
| EFFICACY; Efficacy | SUPPL | 29 | AP | 2022-02-14 | STANDARD | 
| LABELING; Labeling | SUPPL | 33 | AP | 2022-07-12 | STANDARD | 
| LABELING; Labeling | SUPPL | 34 | AP | 2022-07-27 | STANDARD | 
Submissions Property Types
| ORIG | 1 | Null | 25 | 
| SUPPL | 9 | Null | 6 | 
| SUPPL | 10 | Null | 7 | 
| SUPPL | 13 | Null | 15 | 
| SUPPL | 17 | Null | 6 | 
| SUPPL | 18 | Null | 7 | 
| SUPPL | 25 | Null | 15 | 
| SUPPL | 29 | Null | 7 | 
| SUPPL | 33 | Null | 15 | 
| SUPPL | 34 | Null | 6 | 
CDER Filings
GENENTECH
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 125486
            [companyName] => GENENTECH
            [docInserts] => ["",""]
            [products] => [{"drugName":"GAZYVA","activeIngredients":"OBINUTUZUMAB","strength":"1000MG\/40ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"03\/27\/2020","submission":"SUPPL-25","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/125486s025lbl.pdf\"}]","notes":""},{"actionDate":"11\/16\/2017","submission":"SUPPL-18","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/125486s017s018lbl.pdf\"}]","notes":""},{"actionDate":"11\/16\/2017","submission":"SUPPL-17","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/125486s017s018lbl.pdf\"}]","notes":""},{"actionDate":"02\/26\/2016","submission":"SUPPL-13","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/125486s013lbl.pdf\"}]","notes":""},{"actionDate":"09\/23\/2015","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/125486s010lbledt.pdf\"}]","notes":""},{"actionDate":"06\/27\/2014","submission":"SUPPL-8","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/125486_s008lbl.pdf\"}]","notes":""},{"actionDate":"11\/01\/2013","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/125486s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"11\/01\/2013","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/125486s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2013\\\/125486Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2013\\\/125486Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/125486Orig1s000SumR.pdf\"}]","notes":">"}]
            [supplements] => [{"actionDate":"03\/27\/2020","submission":"SUPPL-25","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/125486s025lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/125486Orig1s025ltr.pdf\"}]","notes":">"},{"actionDate":"11\/16\/2017","submission":"SUPPL-18","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/125486s017s018lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/125486Orig1s017s018ltr.pdf\"}]","notes":">"},{"actionDate":"11\/16\/2017","submission":"SUPPL-17","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/125486s017s018lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/125486Orig1s017s018ltr.pdf\"}]","notes":">"},{"actionDate":"02\/26\/2016","submission":"SUPPL-13","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/125486s013lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/125486Orig1s013ltr.pdf\"}]","notes":">"},{"actionDate":"09\/23\/2015","submission":"SUPPL-10","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/125486s010lbledt.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/125486Orig1s010ltr.pdf\"}]","notes":">"},{"actionDate":"12\/24\/2014","submission":"SUPPL-9","supplementCategories":"Supplement","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/125486Orig1s009ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"06\/27\/2014","submission":"SUPPL-8","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/125486_s008lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/125486Orig1s008ltr.pdf\"}]","notes":">"}]
            [actionDate] => 2020-03-27
        )
)